fda compounding semaglutide warning november 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" FDA Warns on Certain Forms

08.01.24 August MDL numbers continued to increase The latest MDL numbers show that an additional 241 new actions were filed, bringing the number of GLP-1 lawsuits to 346

The conversation should not be reduced to whether compulsory licenses ought to be granted

Currently one in eight Americans have used GLP-1 medications with roughly 6% currently using the drug

GLP-1 Users Guide to Protein Snacks: Heres What a Dietitian Actually Recommends From convenient grab-and-go options to whole-food choices, these are the protein snacks worth keeping on hand

OZEMPIC users grew from 569 in 2019 to 7,667 in 2020, then surged to over 13,310 in 2021, surpassing TRULICITY

Provider reviews intake within 4 hours and approves within 24 hours